TITLE

Comparative effectiveness of angiotensin-converting-enzyme inhibitors: Is an ACE always an ace?

AUTHOR(S)
Hernandez, Adrian F.; Harrington, Robert A.
PUB. DATE
May 2008
SOURCE
CMAJ: Canadian Medical Association Journal;5/6/2008, Vol. 178 Issue 10, p1316
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article relates the authors' perspective on the comparative effectiveness study of angiotensin-converting-enzyme (ACE) inhibitors in the treatment of congestive heart failure, published within the issue. They assert that the results of the study suggests that there maybe critical differences in outcomes among the groups of ACE inhibitors commonly used to treat heart failure. However, they argue that further studies are needed to compare ACE's efficacy and validate the study's findings.
ACCESSION #
31772325

 

Related Articles

  • cilazapril.  // Royal Society of Medicine: Medicines;2002, p155 

    The article provides information on the drug cilazapril. Cilazapril is an ACE inhibitor. It is a powerful vasodilator that can be used as an antihypertensive, and in congestive heart failure treatment, often in conjunction with other classes of drug, particularly diuretic drugs. It is...

  • fosinopril.  // Royal Society of Medicine: Medicines;2002, p257 

    The article presents information on fosinopril. The drug is an ACE inhibitor and acts as a vasodilator. It can be used as an antihypertensive and as a congestive heart failure treatment often when other treatments cannot be used. It is frequently administered in conjunction with other classes of...

  • Staril.  // Royal Society of Medicine: Medicines;2002, p508 

    This article presents information on the prescription drug Staril. Staril is a proprietary, prescription-only preparation for the angiotensin converting enzyme inhibitor fosinopril. It can be used as an antihypertensive and in congestive heart failure treatment, and is available as tablets.

  • A case report looking at ACE inhibitors as the cause of angioedema during dental treatment. Raval, P. // British Dental Journal;1/24/2014, Vol. 216 Issue 2, p73 

    Angiotensin converting enzymes, also known as ACE inhibitors are regularly prescribed by doctors in the treatment of congestive heart failure and hypertension. In this case report, we will be looking at the delayed onset of angioedema as a result of ACE inhibitors that occurred during dental...

  • Are Angiotensin-II Antagonists Effective in CHF Treatment? Miller, Karl E. // American Family Physician;10/15/1999, Vol. 60 Issue 6, p1812 

    Presents an abstract of the study `Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure,' by E. P. Havranek et al., from April 1999 issue of the `Journal of American College Cardiology.'

  • Success of a P&T policy for use of a second ACE inhibitor before switching to an ARB.  // Formulary;Feb2002, Vol. 37 Issue 2, p97 

    Focuses on the use of ACE inhibitor therapy for treatment of congestive heart failure in Miami, Florida. Development of policy by Miami VA Medical Center's P & T Committee for the use of ACE inhibitors; Association of captopril and enlapril with highest incidence of cough; Use of Angiotensin II...

  • Tritace.  // Royal Society of Medicine: Medicines;2002, p550 

    The article presents information on tritace, a proprietary, prescription-only preparation of the ace inhibitor ramipril. It can be used as an antihypertensive and in heart failure treatment. It is available in capsule form.

  • Effects of ACE inhibitors in congestive heart failures.  // American Family Physician;10/1/1995, Vol. 52 Issue 5, p1506 

    Reports on a study from the May 10, 1995 issue of the `Journal of the American Medical Association,' by Garg and colleagues who reviewed a variety of studies that examined the effect of ACE inhibitors on morbidity and mortality from congestive heart failures. Reduction of deaths and...

  • Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels. Ajmal, Adnan; Gessert, Charles E.; Johnson, Brian P.; Renier, Colleen M.; Palcher, Jeanette A. // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely used in the management of congestive heart failure (CHF), diabetes mellitus (DM) and hypertension (HTN). Use of these agents is reported to cause anemia. Methods We examined the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics